Clinical Research Directory
Browse clinical research sites, groups, and studies.
Dimethyl Fumarate Treatment for Intracranial Unruptured Aneurysms.
Sponsor: Beijing Tiantan Hospital
Summary
This study was designed to identify whether there is a measurable reduction in inflammation in walls of intracranial aneurysms with oral dimethyl fumarate.
Official title: Dimethyl Fumarate Treatment for Intracranial Unruptured Aneurysms: a Double Blind Randomized Controlled Trail
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2023-07-31
Completion Date
2026-07-31
Last Updated
2026-08-20
Healthy Volunteers
No
Interventions
Dimethyl fumarate
dimethyl fumarate enteric capsule (the initial dose is 120 mg twice a day, and after 7 days, the dose will be increased to the maintenance dose of 240 mg twice a day, for 6 months), 30 patients for this arm.
Placebo
placebo with the same appearance (color, taste, size, shape), 30 patients for this arm.
Locations (1)
Beijing Neurosurgical Institute & Beijing Tiantan Hospital
Beijing, Beijing Municipality, China